Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update By: Theratechnologies via GlobeNewswire June 29, 2023 at 07:30 AM EDT MONTREAL, June 29, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced it will report financial results and provide a business update for its second quarter ended May 31, 2023, on Wednesday, July 12 at 8:30 a.m. EDT. The call will be hosted by Mr. Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque will joined be other members of the management team, including Chief Financial Officer, Mr. Philippe Dubuc, Chief Medical Officer, Dr. Christian Marsolais and Global Commercial Officer, Mr. John Leasure, who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information is below: CONFERENCE CALL INFORMATIONConference Call DateJuly 12, 2023Conference Call Time8:30 a.m. EDTWebcast linkhttps://edge.media-server.com/mmc/p/ot7rcxmrDial in1-888-317-6003 (toll free) or 1-412-317-6061 (international)Access Code0616524 An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’. About TheratechnologiesTheratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Contacts: Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerir@theratech.com 1-438-315-6608 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update By: Theratechnologies via GlobeNewswire June 29, 2023 at 07:30 AM EDT MONTREAL, June 29, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced it will report financial results and provide a business update for its second quarter ended May 31, 2023, on Wednesday, July 12 at 8:30 a.m. EDT. The call will be hosted by Mr. Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque will joined be other members of the management team, including Chief Financial Officer, Mr. Philippe Dubuc, Chief Medical Officer, Dr. Christian Marsolais and Global Commercial Officer, Mr. John Leasure, who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information is below: CONFERENCE CALL INFORMATIONConference Call DateJuly 12, 2023Conference Call Time8:30 a.m. EDTWebcast linkhttps://edge.media-server.com/mmc/p/ot7rcxmrDial in1-888-317-6003 (toll free) or 1-412-317-6061 (international)Access Code0616524 An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’. About TheratechnologiesTheratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Contacts: Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerir@theratech.com 1-438-315-6608
MONTREAL, June 29, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced it will report financial results and provide a business update for its second quarter ended May 31, 2023, on Wednesday, July 12 at 8:30 a.m. EDT. The call will be hosted by Mr. Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque will joined be other members of the management team, including Chief Financial Officer, Mr. Philippe Dubuc, Chief Medical Officer, Dr. Christian Marsolais and Global Commercial Officer, Mr. John Leasure, who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information is below: CONFERENCE CALL INFORMATIONConference Call DateJuly 12, 2023Conference Call Time8:30 a.m. EDTWebcast linkhttps://edge.media-server.com/mmc/p/ot7rcxmrDial in1-888-317-6003 (toll free) or 1-412-317-6061 (international)Access Code0616524 An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’. About TheratechnologiesTheratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Contacts: Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerir@theratech.com 1-438-315-6608